what are the drawbacks of tirzepatide Comparative safety and side effects semaglutide and tirzepatide: Implications for clinical decision-making in obesity management The promise of tirzepatide: A
Description
What if you lost weight and didnt care about anything?
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above if you also have a weight related condition such as type 2 diabetes, high blood pressure, or raised cholesterol
Three major studies recently published in The New England Journal of Medicine highlight progress with oral GLP-1 therapies.
weight-loss drugs, GLP-1 may impair muscle regenerationeven in fasting seniors
Novo sells semaglutide as Ozempic, Rybelsus and Wegovy
This development may broaden access to pharmacologic weight-management options and could act as an accelerator within current obesity-care pathways.
